These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33219884)

  • 21. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic.
    Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
    Cheng HP; Wong JSL; Selveindran NM; Hong JYH
    Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India.
    Khare J; Jindal S
    Prim Care Diabetes; 2022 Dec; 16(6):775-779. PubMed ID: 33419712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
    Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
    Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of COVID-19 lockdown on glycaemic control and use of health services among children followed at a Danish diabetes clinic.
    Kofoed PE; Timm S
    Acta Paediatr; 2022 Feb; 111(2):368-375. PubMed ID: 34586678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscany.
    Bellini B; Nreu B; Francesconi P; Mannucci E
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2588-2593. PubMed ID: 36064691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence.
    Bandarian F; Qorbani M; Aalaa M; Peimani M; Larijani B; Nasli-Esfahani E
    Prim Care Diabetes; 2023 Jun; 17(3):238-241. PubMed ID: 36935271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal observation of general psychopathology before the COVID-19 outbreak and during lockdown in Italy.
    Castellini G; Rossi E; Cassioli E; Sanfilippo G; Innocenti M; Gironi V; Silvestri C; Voller F; Ricca V
    J Psychosom Res; 2021 Feb; 141():110328. PubMed ID: 33316632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Importance of the determination of fructosamine in monitoring diabetic patients].
    Vinci VS; Masotti G; Citro G; De Marca S; Quaglia C; Galasso R
    Medicina (Firenze); 1990; 10(1):25-7. PubMed ID: 2381275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.
    Palanca A; Quinones-Torrelo C; Girbés J; Real JT; Ampudia-Blasco FJ
    Eur J Clin Invest; 2022 Jun; 52(6):e13771. PubMed ID: 35313009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis.
    Ghosal S; Arora B; Dutta K; Ghosh A; Sinha B; Misra A
    Diabetes Metab Syndr; 2020; 14(5):949-952. PubMed ID: 32604013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes.
    Caruso I; Di Molfetta S; Guarini F; Giordano F; Cignarelli A; Natalicchio A; Perrini S; Leonardini A; Giorgino F; Laviola L
    Diabetes Metab Res Rev; 2021 Sep; 37(6):e3404. PubMed ID: 32918324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes.
    Lazzeroni P; Motta M; Monaco S; Laudisio SR; Furoncoli D; Maffini V; Rubini M; Tchana B; Ruberto C; Dodi I; Iovane B
    Acta Biomed; 2021 Nov; 92(5):e2021399. PubMed ID: 34738562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive health beliefs are associated with improvement of glycated hemoglobin and lipid profiles in Mexican patients with type 2 diabetes mellitus: a cross-sectional study.
    Muñoz-Torres AV; Medina-Bravo P; Valerio-Pérez BE; Mendoza-Salmeron G; Escobedo-de la Peña J; Velázquez-López L
    BMC Public Health; 2020 May; 20(1):761. PubMed ID: 32448139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the SARS-CoV-2 pandemic on paediatric patients with type 1 diabetes mellitus after one year of follow-up.
    Gimeno-Hernández Garza V; Antoñanzas Torres I; Pitarch Roca E; Vázquez Sánchez M; Ferrer Lozano M; de Arriba Muñoz A
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):867-873. PubMed ID: 35619192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.
    Biesenbach G; Grafinger P; Raml A
    Wien Klin Wochenschr; 2006 Sep; 118(17-18):543-8. PubMed ID: 17009067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.